In this issue of Neurologic Clinics, guest editor Dr. Carrie M. Hersh brings her considerable expertise to the topic of Multiple Sclerosis. Top experts in the field discuss diagnosis and pathophysiology concepts, treatment, special populations in MS, and contemporary issues related to MS.
Multiple Sclerosis Diagnostic Delay and Misdiagnosis Recent Advances in Diagnostic, Prognostic, and Disease-Monitoring Biomarkers in Multiple Sclerosis Pathophysiology, Diagnosis, Treatment and Emerging Neurotherapeutic Targets for Progressive Multiple Sclerosis: The Age of PIRA Relationship Between Multiple Sclerosis, Gut Dysbiosis, and Inflammation: Considerations for Treatment Updates in NMOSD and MOGAD Diagnosis and Treatment: A Tale of Two Central Nervous System Autoimmune Inflammatory Disorders Advances in Multiple Sclerosis Neurotherapeutics, Neuroprotection, and Risk Mitigation Strategies Role of B Cells in Relapsing-Remitting and Progressive Multiple Sclerosis and Long-Term Effects of B Cell Depletion Brutons Tyrosine Kinase Inhibitors for Multiple Sclerosis Treatment: A New Frontier Autologous Hematopoietic Stem Cell Transplantation to Treat Multiple Sclerosis Highly Effective Therapy Versus Escalation Approaches in Early Multiple Sclerosis: What Is the Future of Multiple Sclerosis Treatment? Leveraging Real-World Evidence and Observational Studies in Treating Multiple Sclerosis Health, Wellness, and the Effect of Comorbidities on the Multiple Sclerosis Disease Course: Tackling the Modifiable Clinical and Treatment Considerations for the Pediatric and Aging Patients with Multiple Sclerosis Womens Health and Pregnancy in Multiple Sclerosis Multiple Sclerosis in Black and Hispanic Populations: Serving the Underserved Era of COVID-19 in Multiple Sclerosis Care
Komentarze (0)
Chwilowo nie możesz polubić tej opinii
Zgłoś komentarz
Czy jesteś pewien, że chcesz zgłosić ten komentarz?
Zgłoszenie wysłane
Twój komentarz został wysłany i będzie widoczny po zatwierdzeniu przez moderatora.